CARDURA-1,2,AND 4 4 MG
DOXAZOSIN (DOXAZOSIN MESYLATE) : 4 MG DOXAZOSIN (DOXAZOSIN MESYLATE) : 2 MG DOXAZOSIN (DOXAZOSIN MESYLATE) : 1 MG · DIN 02231762 · ASTRAZENECA CANADA INC
Health Canada status: CANCELLED PRE MARKET
What is CARDURA-1,2,AND 4?
CARDURA-1,2,AND 4 4 MG contains DOXAZOSIN (DOXAZOSIN MESYLATE) : 4 MG DOXAZOSIN (DOXAZOSIN MESYLATE) : 2 MG DOXAZOSIN (DOXAZOSIN MESYLATE) : 1 MG. It is listed in the Health Canada Drug Product Database under DIN 02231762, held by ASTRAZENECA CANADA INC, supplied as KIT ; TABLET for ORAL administration. Health Canada currently lists it as cancelled pre market, status dated 27-Jul-2023. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is CARDURA-1,2,AND 4 used for?
CARDURA (doxazosin mesylate) is indicated in the treatment of mild to moderate essential hypertension, either as sole therapy or in association with a thiazide diuretic and/or other antihypertensive agents. CARDURA is also indicated for the treatment of symptoms of benign prostatic hyperplasia (BPH) in both hypertensive and normotensive patients.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02231762 |
|---|---|
| Brand name | CARDURA-1,2,AND 4 |
| Generic / active ingredient | DOXAZOSIN (DOXAZOSIN MESYLATE) : 4 MG DOXAZOSIN (DOXAZOSIN MESYLATE) : 2 MG DOXAZOSIN (DOXAZOSIN MESYLATE) : 1 MG |
| Manufacturer | ASTRAZENECA CANADA INC |
| Strength | 4 MG |
| Dosage form | KIT ; TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C02CA04 DOXAZOSIN |
| AHFS class | 24:20.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED PRE MARKET |
| Status date | 27-Jul-2023 |
How is it stored and handled?
null
How is it supplied?
null
What can be used instead?
Other Canadian products sharing ATC code C02CA04 DOXAZOSIN. 9 of 28 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-DOXAZOSIN | 1 MG | TABLET | APOTEX INC | MARKETED | DIN 02240588 |
| APO-DOXAZOSIN | 2 MG | TABLET | APOTEX INC | MARKETED | DIN 02240589 |
| APO-DOXAZOSIN | 4 MG | TABLET | APOTEX INC | MARKETED | DIN 02240590 |
| JAMP-DOXAZOSIN | 1 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02489937 |
| JAMP-DOXAZOSIN | 2 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02489945 |
| JAMP-DOXAZOSIN | 4 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02489953 |
| TEVA-DOXAZOSIN | 1 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 02242728 |
| TEVA-DOXAZOSIN | 2 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 02242729 |
| TEVA-DOXAZOSIN | 4 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 02242730 |
| CARDURA-1 TAB 1MG | 1 MG | TABLET | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 01958100 |
Who else supplies DOXAZOSIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. DOXAZOSIN appears in 79 registered pack listings across 10 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled pre market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.